Strides Arcolab trades jubilantly on getting nod to increase FII limit to 74%

05 Jul 2013 Evaluate

Strides Arcolab is currently trading at Rs. 910.35, up by 27.50 points or 3.11% from its previous closing of Rs. 882.85 on the BSE.

The scrip opened at Rs. 896.95 and has touched a high and low of Rs. 927.85 and Rs. 896.95 respectively. So far 45739 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1224.90 on 05-Dec-2012 and a 52 week low of Rs. 675.25 on 27-Jul-2012.

Last one week high and low of the scrip stood at Rs. 889.90 and Rs. 868.00 respectively. The current market cap of the company is Rs. 5349.78 crore.

The promoters holding in the company stood at 27.39% while Institutions and Non-Institutions held 55.84% and 16.77% respectively.

Bangalore-based pharma major Strides Arcolab has received its board’s approval to increase the limit of investments by Foreign Institutional Investors (FIls) in the equity share of the company from 49 per cent to 74 per cent. The company’s board gave the approval for the same on July 4. 2013.

The ceiling for investment by FIIs in the equity share of the company was capped at 49 per cent of its paid-up equity capital.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

900.65 -39.00 (-4.15%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×